Marathon Pharmaceuticals Names Jeanine Swalec Vice President Of Regulatory Affairs

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Marathon Pharmaceuticals today announced Jeanine M. Swalec has joined the company as its vice president of regulatory affairs.

Swalec, 45, most recently served as the senior director for global regulatory affairs for Lundbeck Pharmaceuticals, which acquired Ovation Pharmaceuticals in 2009.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC